In this two-part podcast, haematologist and clinical researcher Dr Phillip Thompson talks about the exciting changes taking place in treatment of chronic lymphocytic leukaemia, where an expanding array of new agents means we are moving into an era of precision medicine for CLL patients in both front line and relapse treatment. Dr Thompson trained at ...
A new era of precision medicine in CLL: Dr Phillip Thompson
16 Dec 2019
Sponsored by Janssen-Cilag Pty Ltd